The hard to see right (front) heart
|
About UsVentripoint Diagnostics Ltd. (TSXV:VPT, OTCQB:VPTDF), headquartered in Toronto, Canada, is a medical device company engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease – a major cause of death in developed countries and a rapidly rising incidence in emerging countries.
The Ventripoint Medical System (VMS) is the first cost effective and accurate tool for measuring the function of all 4 chambers of the heart, and is the only approved way to generate substantially equivalent results to the gold-standard MRI for right ventricular volumes using 2D echocardiography. Approximately 50% of patients with heart failure have dysfunctional right hearts which go undetected and untreated, leading to repeat hospitalizations. The VMS is designed to reduce healthcare costs while improving quality of life in patients with heart disease. The Company is developing a suite of applications for all major heart diseases and imaging modalities, including congenital heart disease, left or right heart failure and normal hearts - a multi-billion dollar market potential. |
The Ventripoint Medical System
The VMS generates data substantially equivalent
to the MRI |
By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS™) generates accurate heart volumetric measurements and a three-dimensional model in a rapid and inexpensive manner.
The VMS enables medical professionals to economically obtain accurate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers in only a few minutes more than the time needed for a routine echocardiogram. Measuring volume and function is fundamental in evaluating patients to determine the severity and progression of their disease, assess the effectiveness of treatment, gauge prognosis and decide on the timing of surgical and pharmacological interventions. These key measurements and the 3D model for visual assessment provide medical professionals with some of the critical information necessary for clinical diagnosis and monitoring of their patients. |
Our Technology |
Ventripoint's medical technology produces critical heart information by processing standard information received from existing medical imaging equipment with patented and proprietary methods incorporating Knowledge Based Reconstruction (KBR) algorithms and proprietary cardiac databases (sometimes called catalogues). The Company's KBR method allows for the creation of a three-dimensional model of all the chambers of the heart, right and left ventricles and right and left atria, using images generated from existing 2D and 4D imaging equipment (real time 3D imaging is now considered to be 4D with time as the fourth dimension). The Company’s technology platform is applicable to all heart diseases.
The VMS system is based upon patented technology licensed on an exclusive basis from the University of Washington. The VMS has US-FDA marketing clearance, a Health Canada license and European CE Mark for all patients where right heart information is warranted or desired. In addition, the Company received a license from Health Canada for all 4 chambers of the heart on March 2, 2017. |
